TuisDIVISLAB • NSE
add
Divi's Laboratories Ltd
Vorige sluiting
₹5 977,10
Dagwisseling
₹5 980,00 - ₹6 056,95
Jaarwisseling
₹3 350,00 - ₹6 275,85
Markkapitalisasie
1,59 bn INR
Gemiddelde volume
499,58 k
P/V-verhouding
86,78
Dividend-opbrengs
0,50%
Primêre beurs
NSE
Marknuus
Finansieel
Inkomstestaat
Inkomste
Netto inkomste
| (INR) | Sep. 2024info | J/J-verandering |
|---|---|---|
Inkomste | 23,38 mjd | 22,47% |
Bedryfskoste | 7,52 mjd | 5,17% |
Netto inkomste | 5,10 mjd | 46,55% |
Netto winsgrens | 21,81 | 19,64% |
Wins per aandeel | 19,51 | 48,82% |
EBITDA | 7,15 mjd | 49,58% |
Effektiewe belastingkoers | 29,36% | — |
Balansstaat
Totale bates
Totale aanspreeklikheid
| (INR) | Sep. 2024info | J/J-verandering |
|---|---|---|
Kontant en korttermynbeleggings | 36,02 mjd | -0,25% |
Totale bates | 155,86 mjd | 9,12% |
Totale aanspreeklikheid | 18,69 mjd | 16,38% |
Totale ekwiteit | 137,17 mjd | — |
Uitstaande aandele | 265,62 m | — |
Prys om te bespreek | 11,57 | — |
Opbrengs op bates | — | — |
Opbrengs op kapitaal | 11,30% | — |
Kontantvloei
Netto kontantverandering
| (INR) | Sep. 2024info | J/J-verandering |
|---|---|---|
Netto inkomste | 5,10 mjd | 46,55% |
Kontant van bedrywe | — | — |
Kontant van beleggings | — | — |
Kontant van finansiering | — | — |
Netto kontantverandering | — | — |
Beskikbare kontantvloei | — | — |
Meer oor
Divi's Laboratories Limited is an Indian multinational pharmaceutical company and producer of active pharmaceutical ingredients and intermediates, headquartered in Hyderabad. The company manufactures and custom synthesizes generic APIs, intermediates. The company also manufactures and supplies nutraceutical ingredients through its subsidiary, Divi's Nutraceuticals. Divi's Laboratories is India's fourth largest publicly listed pharmaceutical company by market capitalization.
In October 2024, Divi and his family were ranked 29th on Forbes list of India’s 100 richest tycoons, with a net worth of $9.2 billion. Wikipedia
Gestig
12 Okt. 1990
Webwerf
Werknemers
9 741
